Multiple studies have closely examined the circulating levels of PAI-1 in patients with NAFLD, this data showed a correlation between elevated levels of PAI-1 and CVD [35]. The gene discussed is SERPINE1; the disease is metabolic dysfunction-associated steatotic liver disease.